Gardiquimod Unit size Cat. code Docs Qty Price
Imidazoquinoline compound
500 µg
5 mg

Imidazoquinoline compound | TLR7 Agonist

Gardiquimod™ is an imidazoquinoline compound developed and manufactured by InvivoGen. Similarly to Imiquimod, Gardiquimod™ induces the activation of NF-κB in HEK293 cells expressing human or mouse TLR7. Interestingly, Gardiquimod™ is more potent than Imiquimod. Gardiquimod™ is specific for TLR7 when used at less than 1 µg/ml.

Back to the top


Specificity: human/mouse TLR7 agonist

Working concentration: 0.1 - 3 µg/ml

CAS number: 1020412-43-4

Endotoxin level: EndoFit™ (<0.001 EU/μg)

Solubility: 1 mg/ml in water

Back to the top


• Gardiquimod™ is available in two quantities:
- 500 μg Gardiquimod™: tlrl-gdqs
- 5 mg Gardiquimod™: tlrl-gdq-5

• sterile endotoxin-free water, 1.5 ml with #tlrl-gdqs and 10 ml with #tlrl-gdq-5.

Gardiquimod™ is provided lyophilized and shipped at room temperature. Store at -20°C. Lyophilized product is stable for 1 year at -20°C when properly stored. Upon resuspension, prepare ailquots of Gardiquimod™ and store at -20°C for long term storage. Resuspended product is stable for 6 months at -20°C. Avoid repeated freeze-thaw cycles.

Back to the top


Load more

Customer Service
& Technical Support

In order to prevent automated spam submissions, please answer the following question:
1 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Shopping cart is empty